PRRS: A Persistent Disease Threat Shaping Modern Swine Health Management

Porcine Reproductive and Respiratory Syndrome (PRRS) remains one of the most economically devastating viral diseases affecting the global swine industry. Despite decades of control efforts, PRRS continues to challenge herd health, productivity, and biosecurity programs worldwide.

A Disease Impacting the Entire Production Chain

PRRS is caused by Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), which primarily targets macrophages and lead to immunosuppression. Its impact can be seen across all production stages:

• Breeding herd

Reproductive failure including abortions, stillbirths, mummified fetuses, and reduced farrowing performance

• Piglets and nursery pig

Respiratory disease, poor growth, increased morbidity and mortality

• Growing and finishing pig

Reduced average daily gain, poorer feed efficiency, and prolonged time to market.

Beyond acute outbreaks, PRRS is responsible for long-term, cumulative production loss.

Why PRRS Remains Difficult to Control

PRRS is often referred to as a "chronic threat" due to several key disease characteristics:

• High genetic variability, result in limited cross-protection between strains
• Frequent subclinical infections, allow silent circulation within herds
• Synergistic co-infections, worsen respiratory and systemic disease
• Persistent infection, with infected pigs serving as long-term virus reservoirs

These factors make clinical observation alone insufficient for reliable disease assessment.

Disease-Centered Management: From Detection to Control

As PRRS is managed as a long-term endemic disease in many regions, the industry increasingly emphasizes:

• Early identification of viral exposure
• Continuous monitoring of herd immune status
• Differentiation between vaccine-induced immunity and field virus exposure
• Supporting decisions on isolation, herd stabilization, and biosecurity measures

Disease management strategies are shifting from reactive outbreak control to ongoing surveillance and risk-based decision-making.

Antibody Test Is Changing the Logic of PRRS Management

PRRSV antibody test is increasingly recognized by veterinarians and large-scale producers as a core tool in modern PRRS control programs, offering value beyond simple disease confirmation.

Key applications include:

• Evaluation of vaccination effectiveness

Antibody testing helps determine whether vaccination has induced an adequate immune response at both individual and herd levels.

• Monitoring herd immunity uniformity

Identifies immune gaps or sub-optimally protected animals that may compromise overall herd stability.

• Support for gilt introduction and grouping strategies

Provides objective data to guide quarantine, acclimation, and mixing decisions.

• Biosecurity and early warning support

Helps detect potential silent circulation of PRRSV before clinical signs or production losses become apparent.

Compared with reliance on clinical signs alone, antibody testing delivers objective, measurable, and actionable insights into herd health status.

Industry Trend: From "Is There Infection?" to "Is Immunity Effective?"

Across the industry, PRRS control strategies are shifting:

From passive outbreak response

To immunity-centered, long-term management approaches

The availability of rapid, stable, and easy-to-use PRRSV antibody test is making routine immune monitoring more feasible at the farm level. As test becomes better integrated into daily management workflows, monitoring frequency increases-and decision-making becomes more proactive.

Conclusion

PRRS is unlikely to be eradicated in the near future, but its impact can be reduced through informed disease management. A disease-focused approach-centered on understanding viral circulation and herd immunity-has become essential for maintaining stable swine production.